Literature DB >> 3704351

Clofazimine-induced bull's-eye retinopathy.

J M Craythorn, M Swartz, D J Creel.   

Abstract

Bull's-eye retinopathy has multiple associations. We report a case of bull's-eye retinopathy presumed to be secondary to clofazimine (Lamprene) treatment of a 30-year-old patient with acquired immunodeficiency syndrome (AIDS). Pretreatment baseline eye exam of this patient was normal except for bilateral cotton-wool spots. However, follow-up exam 5 months later revealed bilateral anterior pigmentary corneal deposits in a whorl pattern, a presumed infectious retinitis in the left eye, and bilateral annular macular pigmentary abnormalities. The patient was taken off clofazimine treatment, but died 1 month later. The authors suggest that patients being treated with clofazimine be examined for drug-related corneal and retinal lesions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3704351

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  7 in total

Review 1.  Ocular toxicity from systemically administered xenobiotics.

Authors:  Mitan R Gokulgandhi; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-07-18       Impact factor: 4.481

Review 2.  Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases.

Authors:  Victor Chi; Michael W Pennington; Raymond S Norton; Eric J Tarcha; Luz M Londono; Brian Sims-Fahey; Sanjeev K Upadhyay; Jonathan T Lakey; Shawn Iadonato; Heike Wulff; Christine Beeton; K George Chandy
Journal:  Toxicon       Date:  2011-08-12       Impact factor: 3.033

Review 3.  The Mycobacterium avium complex.

Authors:  C B Inderlied; C A Kemper; L E Bermudez
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

Review 4.  The functional network of ion channels in T lymphocytes.

Authors:  Michael D Cahalan; K George Chandy
Journal:  Immunol Rev       Date:  2009-09       Impact factor: 12.988

5.  Crystalline deposition in the cornea and conjunctiva secondary to long-term clofazimine therapy in a leprosy patient.

Authors:  Rakesh K Barot; Vishalakshi Viswanath; Madhuri S Pattiwar; Raghunandan G Torsekar
Journal:  Indian J Ophthalmol       Date:  2011 Jul-Aug       Impact factor: 1.848

6.  Clofazimine-induced premaculopathy in a vitiliginous patient.

Authors:  Nirupama Kasturi; Renuka Srinivasan
Journal:  J Pharmacol Pharmacother       Date:  2016 Jul-Sep

7.  Ocular Side Effects of Systemic Drugs Used in Dermatology.

Authors:  Bhanu Prakash; H Mohan Kumar; Saranya Palaniswami; Borra Harish Lakshman
Journal:  Indian J Dermatol       Date:  2019 Nov-Dec       Impact factor: 1.494

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.